124 related articles for article (PubMed ID: 8084608)
1. A single nucleotide substitution at codon 31 (Ser/Arg) defines a polymorphism in a highly conserved region of the p53-inducible gene WAF1/CIP1.
Chedid M; Michieli P; Lengel C; Huppi K; Givol D
Oncogene; 1994 Oct; 9(10):3021-4. PubMed ID: 8084608
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer.
Li YJ; Laurent-Puig P; Salmon RJ; Thomas G; Hamelin R
Oncogene; 1995 Feb; 10(3):599-601. PubMed ID: 7845685
[TBL] [Abstract][Full Text] [Related]
3. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer.
Ralhan R; Agarwal S; Mathur M; Wasylyk B; Srivastava A
Clin Cancer Res; 2000 Jun; 6(6):2440-7. PubMed ID: 10873097
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of the p21/WAF1/CIP1/SDI1 coding region in human tumor cell lines.
Terry LA; Boyd J; Alcorta D; Lyon T; Solomon G; Hannon G; Berchuck A; Beach D; Barrett JC
Mol Carcinog; 1996 Aug; 16(4):221-8. PubMed ID: 8784465
[TBL] [Abstract][Full Text] [Related]
5. Novel polymorphism in p21(waf1/cip1) cyclin dependent kinase inhibitor gene: association with human esophageal cancer.
Bahl R; Arora S; Nath N; Mathur M; Shukla NK; Ralhan R
Oncogene; 2000 Jan; 19(3):323-8. PubMed ID: 10656678
[TBL] [Abstract][Full Text] [Related]
6. Low levels of expression of an inhibitor of cyclin-dependent kinases (CIP1/WAF1) in primary breast carcinomas with p53 mutations.
Ozçelik H; Mousses S; Andrulis IL
Clin Cancer Res; 1995 Aug; 1(8):907-12. PubMed ID: 9816061
[TBL] [Abstract][Full Text] [Related]
7. Altered WAF1 genes do not play a role in abnormal cell cycle regulation in breast cancers lacking p53 mutations.
McKenzie KE; Siva A; Maier S; Runnebaum IB; Seshadri R; Sukumar S
Clin Cancer Res; 1997 Sep; 3(9):1669-73. PubMed ID: 9815858
[TBL] [Abstract][Full Text] [Related]
8. Somatic mutations of the WAF1/CIP1 gene in primary prostate cancer.
Gao X; Chen YQ; Wu N; Grignon DJ; Sakr W; Porter AT; Honn KV
Oncogene; 1995 Oct; 11(7):1395-8. PubMed ID: 7478562
[TBL] [Abstract][Full Text] [Related]
9. Multiple polymorphisms, but no mutations, in the WAF1/CIP1 gene in human brain tumours.
Koopmann J; Maintz D; Schild S; Schramm J; Louis DN; Wiestler OD; von Deimling A
Br J Cancer; 1995 Nov; 72(5):1230-3. PubMed ID: 7577473
[TBL] [Abstract][Full Text] [Related]
10. p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer.
Roh JW; Kim JW; Park NH; Song YS; Park IA; Park SY; Kang SB; Lee HP
Gynecol Oncol; 2004 May; 93(2):499-505. PubMed ID: 15099969
[TBL] [Abstract][Full Text] [Related]
11. A mutant p21 cyclin-dependent kinase inhibitor isolated from a Burkitt's lymphoma.
Bhatia K; Fan S; Spangler G; Weintraub M; O'Connor PM; Judde JG; Magrath I
Cancer Res; 1995 Apr; 55(7):1431-5. PubMed ID: 7882347
[TBL] [Abstract][Full Text] [Related]
12. Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression.
Kralj M; Husnjak K; Körbler T; Pavelić J
Cancer Gene Ther; 2003 Jun; 10(6):457-67. PubMed ID: 12768191
[TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis by the p53-273L (Arg --> Leu) mutant in HSC3 cells without transactivation of p21Waf1/Cip1/Sdi1 and bax.
Kaneuchi M; Yamashita T; Shindoh M; Segawa K; Takahashi S; Furuta I; Fujimoto S; Fujinaga K
Mol Carcinog; 1999 Sep; 26(1):44-52. PubMed ID: 10487521
[TBL] [Abstract][Full Text] [Related]
14. Expression and sequence analysis of the p21(WAF1/CIP1) gene in renal cancers.
Papandreou CN; Bogenrieder T; Loganzo F; Albino AP; Nanus DM
Urology; 1997 Mar; 49(3):481-6. PubMed ID: 9123723
[TBL] [Abstract][Full Text] [Related]
15. WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium.
Lukas J; Groshen S; Saffari B; Niu N; Reles A; Wen WH; Felix J; Jones LA; Hall FL; Press MF
Am J Pathol; 1997 Jan; 150(1):167-75. PubMed ID: 9006333
[TBL] [Abstract][Full Text] [Related]
16. Association of p53 and p21(CDKN1A/WAF1/CIP1) polymorphisms with oral cancer in Taiwan patients.
Bau DT; Tsai MH; Lo YL; Hsu CM; Tsai Y; Lee CC; Tsai FJ
Anticancer Res; 2007; 27(3B):1559-64. PubMed ID: 17595776
[TBL] [Abstract][Full Text] [Related]
17. Histone H3 acetylation is associated with reduced p21(WAF1/CIP1) expression by gastric carcinoma.
Mitani Y; Oue N; Hamai Y; Aung PP; Matsumura S; Nakayama H; Kamata N; Yasui W
J Pathol; 2005 Jan; 205(1):65-73. PubMed ID: 15586362
[TBL] [Abstract][Full Text] [Related]
18. [Detection of point mutations in promoter and coding sequence of p21 gene in a variety of human malignancies].
Huang Q; Tao Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Jun; 17(3):169-72. PubMed ID: 10837517
[TBL] [Abstract][Full Text] [Related]
19. Analysis of p21WAF1/CIP1 in primary bladder tumors.
Lacombe L; Orlow I; Silver D; Gerald WL; Fair WR; Reuter VE; Cordon-Cardo C
Oncol Res; 1996; 8(10-11):409-14. PubMed ID: 9114433
[TBL] [Abstract][Full Text] [Related]
20. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
